Showing results (61-70 of 85) with videos related to
Sort By:
Pageof 9
British Journal of Haematology|February 16, 2024
Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in ChinaZhifa Wang, Aijun Zhang, Zhongjin Xu, et al.British Journal of Haematology|July 16, 2025
Machine learning to forecast rituximab responses for paediatric immune thrombocytopenia: Forging a path towards personalized medical careJingyao Ma, Chang Cui, Juntao Ouyang, et al.Science Advances|October 22, 2025
A multistep platform identifies spleen-tropic lipid nanoparticles for in vivo T cell-targeted delivery of gene-editing proteinsXiaoya Lu, Yining Zhu, Christine Wei, et al.Research and Practice in Thrombosis and Haemostasis|December 11, 2025
Rituximab-first versus eltrombopag monotherapy in pediatric persistent/chronic immune refractory thrombocytopenia after first-line therapy: a prospective multicenter cohort studyJingyao Ma, Zhifa Wang, Juntao Ouyang, et al.Journal of Ethnopharmacology|December 20, 2025
The efficacy and safety of Huaiqihuang Granule in the treatment of childhood chronic primary immune thrombocytopenia: a multi-centre, randomized, double-blind, placebo-controlled clinical study ()Juan Han, Qiang Fu, Changda Liang, et al.Molecular Therapy. Nucleic Acids|February 19, 2025
Use of polyadenosine tail mimetics to enhance mRNA expression from genes associated with haploinsufficiency disordersBahareh Torkzaban, Yining Zhu, Christian Lopez, et al.Nature|July 1, 2026
N<sup>4</sup>-Acetylcytidine enhances synthetic mRNA translation yield and fidelitySarah Schiffers, Blake W Nelson, Maria Prigge, et al.Annals of Hematology|June 8, 2026
Prediction of avatrombopag-induced thrombocytosis in pediatric immune thrombocytopenia: an AI-based real-world studyXi Lin, Yuntian Wang, Yunqi Zhu, et al.Haematologica|May 7, 2026
Overuse of thrombopoietin receptor agonists driven by suboptimal response is associated with myelofibrosis in pediatric immune thrombocytopeniaJingyao Ma, Zhenping Chen, Xiaoling Cheng, et al.Materials Today (Kidlington, England)|June 1, 2026
Imidazolium Lipid-based Nanoparticles Enable Effective mRNA Delivery and Cellular Immune ResponseJinghan Lin, Yining Zhu, Leonardo Cheng, et al.Pageof 9